zoom_in Click to enlarge

Katalin Kariko

▲ ▼

description Katalin Kariko Overview

Katalin Kariko was a Hungarian-American biochemist whose pioneering work with messenger RNA (mRNA) fundamentally advanced vaccine technology. Her research, initially conducted in the late 20th century and continued through the 21st, provided the critical foundation for the rapid development of mRNA vaccines against COVID-19. Kariko’s contributions were recognized with the 2023 Nobel Prize in Physiology or Medicine, solidifying her legacy as a key figure in modern medicine and biotechnology. This work is particularly relevant to scientists, researchers, and healthcare professionals involved in vaccine development and immunology.

help Katalin Kariko FAQ

What did Katalin Kariko discover?

Katalin Kariko pioneered the use of messenger RNA (mRNA) technology for medical therapies. Her decades of research with colleague Drew Weissman led to the modification of synthetic mRNA, preventing it from triggering a severe immune response.

How did Katalin Kariko's research impact the COVID-19 pandemic?

Her foundational mRNA modifications were directly utilized to develop the highly effective Pfizer-BioNTech and Moderna COVID-19 vaccines. This technology allowed for the rapid development and deployment of vaccines during the global pandemic.

Did Katalin Kariko win a Nobel Prize?

Yes, Katalin Kariko and Drew Weissman were jointly awarded the Nobel Prize in Physiology or Medicine in 2023. They received the award for their discoveries concerning nucleoside base modifications that enabled the development of mRNA vaccines.

Where did Katalin Kariko conduct her research?

Kariko spent much of her career conducting research at the University of Pennsylvania. Despite struggling for years to secure funding for her mRNA research, she persisted before eventually moving to BioNTech as a senior vice president.